Author:
Faggioli Guglielmo,Menotti Laura,Marchesin Stefano,Chió Adriano,Dagliati Arianna,de Carvalho Mamede,Gromicho Marta,Manera Umberto,Tavazzi Eleonora,Di Nunzio Giorgio Maria,Silvello Gianmaria,Ferro Nicola
Abstract
AbstractAutomatic disease progression prediction models require large amounts of training data, which are seldom available, especially when it comes to rare diseases. A possible solution is to integrate data from different medical centres. Nevertheless, various centres often follow diverse data collection procedures and assign different semantics to collected data. Ontologies, used as schemas for interoperable knowledge bases, represent a state-of-the-art solution to homologate the semantics and foster data integration from various sources. This work presents the BrainTeaser Ontology (BTO), an ontology that models the clinical data associated with two brain-related rare diseases (ALS and MS) in a comprehensive and modular manner. BTO assists in organizing and standardizing the data collected during patient follow-up. It was created by harmonizing schemas currently used by multiple medical centers into a common ontology, following a bottom-up approach. As a result, BTO effectively addresses the practical data collection needs of various real-world situations and promotes data portability and interoperability. BTO captures various clinical occurrences, such as disease onset, symptoms, diagnostic and therapeutic procedures, and relapses, using an event-based approach. Developed in collaboration with medical partners and domain experts, BTO offers a holistic view of ALS and MS for supporting the representation of retrospective and prospective data. Furthermore, BTO adheres to Open Science and FAIR (Findable, Accessible, Interoperable, and Reusable) principles, making it a reliable framework for developing predictive tools to aid in medical decision-making and patient care. Although BTO is designed for ALS and MS, its modular structure makes it easily extendable to other brain-related diseases, showcasing its potential for broader applicability.Database URL https://zenodo.org/records/7886998.
Funder
Horizon 2020 Framework Programme
Università degli Studi di Padova
Publisher
Springer Science and Business Media LLC
Reference81 articles.
1. Schaefer J, Lehne M, Schepers J, Prasser F, Thun S. The use of machine learning in rare diseases: a scoping review. Orphanet J Rare Dis. 2020;15:1–10.
2. Calvanese D, Giacomo GD, Lembo D, Lenzerini M, Rosati R. In: Liu L, Özsu MT, editors. Ontology-based data access and integration. New York: Springer New York; 2018. pp. 2590–2596. https://doi.org/10.1007/978-1-4614-8265-9_80667.
3. Alshamrani R, Althbiti A, Alshamrani Y, Alkomah F, Ma X. Model-Driven Decision Making in Multiple Sclerosis Research: Existing Works and Latest Trends. Patterns. 2020;1(8):100121. https://doi.org/10.1016/j.patter.2020.100121.
4. Guazzo A, Trescato I, Longato E, Hazizaj E, Dosso D, Faggioli G, et al. Overview of iDPP@CLEF 2022: The Intelligent Disease Progression Prediction Challenge. In: Proceedings of the Working Notes of CLEF 2022 - Conference and Labs of the Evaluation Forum. CEUR Workshop Proceedings, vol. 3180. 2022. pp. 1130–1210. https://ceur-ws.org/Vol-3180/paper-88.pdf.
5. Guazzo A, Trescato I, Longato E, Hazizaj E, Dosso D, Faggioli G, et al. Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2022. In: Experimental IR Meets Multilinguality, Multimodality, and Interaction - 13th International Conference of the CLEF Association, CLEF 2022, Bologna, Italy, September 5-8, 2022, Proceedings. Lecture Notes in Computer Science, vol. 13390. 2022. pp. 395–422. https://doi.org/10.1007/978-3-031-13643-6_25.